← SynDRA
BMS-387032
SynDRA canonical compound SYN0002373 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | CDK9 |
|---|
| Mechanism of action | Cell cycle inhibitor |
|---|
All known targets
- CDK2
- CDK9
- CDK7
- CDK1
- CDK4
- MCL1
Mechanisms of action (all sources)
- cyclin-dependent kinase inhibitor
- MCL1 INHIBITOR
- Cell cycle inhibitor
- CDK2 INHIBITOR
- Cyclin-dependent kinase 2 inhibitor
- CDK7 INHIBITOR
- Cyclin-dependent kinase 7 inhibitor
- CDK9 INHIBITOR
- Cyclin-dependent kinase 9 inhibitor
- CDK1 INHIBITOR
- CDK4/6 inhibitor
Cross-references
Synonyms
- Bms387032
- SNS-032
- BMS-387072
- BMS-387032, SNS-032
- N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide L-tartaric acid salt (2:1)
- N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide
- N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide
- SNS 032
- BMS387032
- CHEBI:91399
- RefChem:886481
- DTXCID40110591
- SNS-032 (BMS-387032)
- SNS032
- MFCD09833875
- SNS-032 (hydrochloride)
- Kinome_3820
- OUSFTKFNBAZUKL-UHFFFAOYSA-N
- UNII-9979I93686
- MLS006011029
- SCHEMBL187401
- BDBM5931
- GTPL5670
- orb1301119
- SNS 032 [WHO-DD]
- cid_3025986
- EX-A054
- HMS3295G09
- HMS3654G10
- EBC-11329
- NSC767048
- NSC799362
- s1145
- AKOS015898717
- CCG-264835
- FS16408
- NSC-767048
- NSC-799362
Look up BMS-387032 in the interactive SynDRA portal →